Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company dedicated to advancing life-changing medicines for rare disease patients across Europe, has announced the appointment of Abdelghani (Abdel) Omari as its first-ever…
Vertex Pharmaceuticals Announces Landmark Reimbursement Agreement with NHS England, Expanding Access to CASGEVY® for Sickle Cell Disease Patients Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has revealed a significant milestone in the…
TWYMEEG® Sales Performance and Forecast Update Poxel’s Partner Sumitomo Pharma Reports TWYMEEG® Sales for Q4 and FY 2024 in Japan A clinical-stage biopharmaceutical company dedicated to developing innovative treatments for…
KORU Medical Systems Announces Strategic Collaboration for Phase III Clinical Trial on Expanded Drug Indication for Rare Renal Disorder KORU Medical Systems (NASDAQ: KRMD), a prominent medical technology company focused…
TROPION-Lung12 Phase 3 Trial Begins to Evaluate DATROWAY® as Part of Adjuvant Treatment for High-Risk Early-Stage Non-Small Cell Lung Cancer Patients Non-small cell lung cancer (NSCLC) is the most common…
Enveric Biosciences Announces Notice of Allowance for Patent on Lead Drug Candidate EB-003 Enveric Biosciences, a biotechnology firm focused on pioneering neuroplastogenic small-molecule therapeutics for mental health disorders, announced today…
Science Exchange Launches Clinical Development Solution to Revolutionize Clinical Trial Management Science Exchange, a leader in supplier orchestration solutions for the life sciences industry, has unveiled its new Clinical Development…
Mirvie, a leader in personalized and preventive care for pregnancy complications, recently presented groundbreaking findings at the Society for Maternal-Fetal Medicine annual meeting. The company revealed that its innovative RNA…
Kyowa Kirin and Swixx BioPharma Expand Access to POTELIGEO® for Mycosis Fungoides and Sézary Syndrome in Central and Eastern Europe Kyowa Kirin International (KKI), a fully owned subsidiary of Kyowa…
Osta Therapeutics Expands Leadership Team with Two Industry Experts to Combat Antibiotic Resistance Osta Therapeutics Expands Leadership Team to Tackle Antibiotic Resistance Osta Therapeutics, a biotechnology company focused on developing…
Ethris Announces Promising Phase 1 Clinical Data for mRNA Therapeutic ETH47 in Asthma Treatment Ethris GmbH, a biotechnology pioneer in the development of next-generation RNA therapeutics and vaccines, has announced…
Owkin, a pioneering AI-biotech company dedicated to transforming drug discovery, development, and diagnostics through agentic AI, has announced the dosing of the first patient in its Phase I clinical trial…